Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jayne

Showing results (11-20 of 340) with videos related to

Pageof 34
Sort By:
Best Practice & Research. Clinical Rheumatology|April 29, 2005
How to induce remission in primary systemic vasculitisDavid Jayne
Presse Medicale (Paris, France : 1983)|March 16, 2013
L27. Antibodies versus phenotypes: a clinician's viewDavid Jayne
EULAR Rheumatology Open|June 29, 2026
Update on therapeutic approaches in ANCA-associated vasculitisDavid Jayne
Nephrologie & Therapeutique|October 22, 2019
Complement inhibition in ANCA vasculitisDavid Jayne
Japanese Journal of Infectious Diseases|October 28, 2004
The clinical features and pathology of vasculitis associated with anti-myeloperoxidase autoantibodiesDavid Jayne
Best Practice & Research. Clinical Rheumatology|June 11, 2009
The vasculitic diseasesDavid Jayne
Rheumatology (Oxford, England)|November 3, 2025
Addressing clinical challenges in ANCA-associated vasculitis with real-world evidenceDavid Jayne
Current Opinion in Rheumatology|February 19, 2008
Challenges in the management of microscopic polyangiitis: past, present and futureDavid Jayne
The Journal of Rheumatology|March 2, 2021
Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now?David Jayne
Rheumatology (Oxford, England)|March 12, 2025
Emerging targeted therapies in ANCA-associated vasculitisDavid Jayne
Pageof 34

Showing results (11-20 of 340) with videos related to

Sort By:
Pageof 34
Best Practice & Research. Clinical Rheumatology|April 29, 2005
How to induce remission in primary systemic vasculitisDavid Jayne
Presse Medicale (Paris, France : 1983)|March 16, 2013
L27. Antibodies versus phenotypes: a clinician's viewDavid Jayne
EULAR Rheumatology Open|June 29, 2026
Update on therapeutic approaches in ANCA-associated vasculitisDavid Jayne
Nephrologie & Therapeutique|October 22, 2019
Complement inhibition in ANCA vasculitisDavid Jayne
Japanese Journal of Infectious Diseases|October 28, 2004
The clinical features and pathology of vasculitis associated with anti-myeloperoxidase autoantibodiesDavid Jayne
Best Practice & Research. Clinical Rheumatology|June 11, 2009
The vasculitic diseasesDavid Jayne
Rheumatology (Oxford, England)|November 3, 2025
Addressing clinical challenges in ANCA-associated vasculitis with real-world evidenceDavid Jayne
Current Opinion in Rheumatology|February 19, 2008
Challenges in the management of microscopic polyangiitis: past, present and futureDavid Jayne
The Journal of Rheumatology|March 2, 2021
Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now?David Jayne
Rheumatology (Oxford, England)|March 12, 2025
Emerging targeted therapies in ANCA-associated vasculitisDavid Jayne
Pageof 34